5AM Venture Management’s scPharmaceuticals SCPH Stock Holding History

5AM Venture Management’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,200,647	Closed	-$4.57M	–	27
2025 Q2	$4.57M	Hold	1,200,647	–	–	1.76%	19
2025 Q1	$3.16M	Hold	1,200,647	–	–	1.19%	24
2024 Q4	$4.25M	Hold	1,200,647	–	–	1.01%	22
2024 Q3	$5.47M	Hold	1,200,647	–	–	1.13%	21
2024 Q2	$5.22M	Hold	1,200,647	–	–	1.17%	21
2024 Q1	$6.03M	Hold	1,200,647	–	–	1.35%	22
2023 Q4	$7.53M	Hold	1,200,647	–	–	2%	17
2023 Q3	$8.55M	Hold	1,200,647	–	–	2.46%	11
2023 Q2	$12.2M	Hold	1,200,647	–	–	3.05%	9
2023 Q1	$10.9M	Sell	1,200,647 -1,534,205	-56%	-$11.2M	2.78%	8
2022 Q4	$19.6M	Sell	2,734,852 -600,000	-18%	-$3.67M	5.27%	7
2022 Q3	$21.7M	Sell	3,334,852 -226,622	-6%	-$1.21M	4.17%	7
2022 Q2	$17.2M	Sell	3,561,474 -270,000	-7%	-$1.34M	4.25%	9
2022 Q1	$21.8M	Hold	3,831,474	–	–	4.75%	7
2021 Q4	$19.2M	Hold	3,831,474	–	–	3.61%	10
2021 Q3	$25.5M	Hold	3,831,474	–	–	5.17%	10
2021 Q2	$23.4M	Hold	3,831,474	–	–	5.89%	9
2021 Q1	$25.5M	Hold	3,831,474	–	–	4.59%	7
2020 Q4	$20.3M	Hold	3,831,474	–	–	6.83%	6
2020 Q3	$28.5M	Hold	3,831,474	–	–	7.51%	6
2020 Q2	$28.2M	Buy	3,831,474 +578,034	+18%	+$5.08M	6.18%	7
2020 Q1	$24.1M	Hold	3,253,440	–	–	7.45%	6
2019 Q4	$18.4M	Buy	+3,253,440	New	+$16.6M	3.96%	7

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

5AM Venture Management's SCPH Position: Q3 2025 in Review

5AM Venture Management sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 1,200,647 shares — an estimated $4.57M sold.

5AM Venture Management first reported a position in SCPH in Q4 2019 and held it in 23 quarters. The position peaked at $28.5M in Q3 2020. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

5AM Venture Management reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
5AM Venture Management sold 1,200,647 scPharmaceuticals shares in Q3 2025, an estimated $4.57M.
5AM Venture Management first reported a position in scPharmaceuticals in Q4 2019 and held it in 23 quarters.
5AM Venture Management's scPharmaceuticals position peaked at $28.5M in Q3 2020.
110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on 5AM Venture Management's 13F filing for Q3 2025, filed 14 Nov 2025.